Orange Book product · Generic (ANDA)
VENLAFAXINE HYDROCHLORIDE
VENLAFAXINE HYDROCHLORIDE
At a glance
Apr 04, 2023
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 04, 2023
3 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
VENLAFAXINE HYDROCHLORIDE
Strength
EQ 37.5MG BASE
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
ANDA 200430
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of VENLAFAXINE HYDROCHLORIDE
- 2008VENLAFAXINE HYDROCHLORIDEBrand (NDA)
NDA 022104 · OSMOTICA PHARM US
- 1997EFFEXOR XRBrand (NDA)
NDA 020699 · UPJOHN
- 1993EFFEXORBrand (NDA)
NDA 020151 · WYETH PHARMS INC
- 2025VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217841 · ABON PHARMS LLC
- 2025VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218180 · TORRENT
- 2024VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217767 · ALEMBIC
- 2023VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217390 · GRANULES
- 2023VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214691 · AJANTA PHARMA LTD
- 2022VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216044 · UNIQUE
- 2022VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215622 · ZYDUS PHARMS
- 2022VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214423 · PHARMADAX
- 2021VENLAFAXINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214654 · YICHANG HUMANWELL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
